[Pyoderma gangrenosum: Clofazimine therapy].
Two patients with pyoderma gangrenosum have responded remarkably well to treatment with Clofazimine (Lamprène). The first patient, a 68-year old women suffered from pyoderma gangrenosum of the buttock and left leg and on the incision scar for cancer of the breast. Laboratory findings showed monoclonal dysglobulinemia (alpha 2-kappa 2). A daily dose of 300 mg of Clofazimine resulted in complete healing with ten days. The second patient was a 24-year old women suffering from ulcerative colitis and a rapidly progressing pyoderma gangrenosum of the left leg. The lesions was completely healed after two weeks of Clofazimine therapy. The dosage was 200 mg daily and was increased to 400 mg daily. Our cases showed decreased cellular immunity and their phagocytic activity was variable.
D000328:Adult; D000368:Aged; D002991:Clofazimine / Q000627:therapeutic use*; D005260:Female; D005734:Gangrene; D006801:Humans; D007111:Immunity, Cellular; D011711:Pyoderma / Q000188:drug therapy* / Q000276:immunology
D002991:Clofazimine
Pyoderma gangrenosum: thérapeutique par clofazimine.